KMT2A and acute lymphoblastic leukemia: Andersson et al. recently showed that additional somatic mutations in MLL-rearranged infant ALL, like (sub-)clonal RAS/PI3K pathway aberrations, occur in up to 50% of the cases, supporting our previous observation that RAS mutations in MLL-rearranged infant ALL frequently occur at a sub-clonal level [3, 19].